Clinical Trials Logo
  1. Home
  2. Female Pattern Baldness
  3. NCT05824065

Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss — GENERA  

Female Pattern Baldness Clinical Trial

Official title:
Phase III, National, Multicenter, Randomized, Double-Blind, Superiority Clinical Trial to Evaluate the Efficacy and Safety of OMA102 in the Treatment of Female Pattern Hair Loss

Clinical Trial Summary

The goal of this clinical trial is to evaluate the efficacy and safety of OMA102 1 mg and OMA102 2 mg versus placebo in the treatment of female pattern hair loss.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05824065
Study type Interventional
Source EMS
Contact Cassiano Ricardo O Berto, B.S.
Phone +551938877724
Email pesquisa.clinica@ncfarma.com.br
Status Not yet recruiting
Phase Phase 3
Start date January 2025
Completion date January 2027
View Details
See also
  Status Clinical Trial Phase
Completed NCT00981461 - Treatment of Androgenetic Alopecia in Females, 9 Beam N/A
Completed NCT01451021 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss Phase 2
Completed NCT01451138 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004541) Phase 2
Completed NCT03351322 - ENERGI-F701 for Female Hair Loss Treatment Phase 2
Completed NCT01451177 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669) Phase 2
Completed NCT01451125 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004512) Phase 2
Recruiting NCT06333600 - Efficacy and Safety of Topical Vitamin D Analogue in Treatment of Female Pattern Hair Loss Phase 1/Phase 2
Not yet recruiting NCT05409755 - Radiofrequency in Female Pattern Hair Loss N/A
Not yet recruiting NCT05888922 - Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia Phase 3
Completed NCT01669746 - A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0006931) Phase 2
Completed NCT01451099 - A Study to Evaluate and Compare Injections of Autologous Dermal Cells Into the Balding Scalp of Subjects With Hair Loss Phase 2
Withdrawn NCT04379583 - HairDx Analytical Validation Study
Completed NCT01451190 - A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0005995) Phase 2
Completed NCT01451047 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002012) Phase 2
Not yet recruiting NCT02316418 - Hairstetics™ Anchoring System in Female Pattern Hair Loss (HAS-FPHL) N/A
Completed NCT01016964 - Treatment of Androgenetic Alopecia in Females, 12 Beam N/A
Completed NCT01451073 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002013) Phase 2
Completed NCT01451151 - A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542) Phase 2
Completed NCT04898166 - Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19).
Completed NCT01451112 - A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002899) Phase 2